Comparison of the Clinical Efficacy of Ampicillin/Sulbactam and Cefoperazone/Sulbactam Against Multidrug Resistant Acinetobacter Baumannii Infections in Critically Ill Patients

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Acinetobacter Baumannii Infection
Interventions
DRUG

Cefoperazone-sulbactam injection

Two grams of Cefoperazone/sulbactam IV are administered every 8 hours, and each dose is administered as an extended infusion over 4 hours. The solution is diluted with a compatible solution (normal saline 0.9%) with a maximum final concentration of 250 mg/ml

DRUG

Ampicillin - Sulbactam Injection

Two grams of Ampicillin/sulbactam IV are administered every 8 hours, and each dose is administered as an extended infusion over 4 hours. The solution is diluted with a compatible solution (normal saline 0.9%) with a final concentration not exceeding 45mg/ml.

Trial Locations (1)

11562

RECRUITING

Cairo university hospitals kasr alainy, Cairo

All Listed Sponsors
lead

Cairo University

OTHER